[
    {
        "other_ids": [],
        "amendment_date": null,
        "keywords": [
            "HER-2",
            "NK Cell",
            "Immunotherapy",
            "Metastatic Breast Cancer",
            "Urothelial Bladder Cancer",
            "Gastric Cancer",
            "Esophageal Cancer",
            "Gastroesophageal Junction Cancer",
            "Non-small Cell Lung Cancer",
            "Erbb2",
            "DF1001"
        ],
        "dcp_id": null,
        "interventional_model": "SEQUENTIAL_ASSIGNMENT",
        "lead_org": "Dragonfly Therapeutics",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Inclusion Criteria: General (applies to all cohorts)\r\n\r\n          1. Signed written informed consent.\r\n\r\n          2. Male or female patients aged \u2265 18 years.\r\n\r\n          3. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 at study entry\r\n             and an estimated life expectancy of at least 3 months.\r\n\r\n          4. Baseline Left Ventricular Ejection Fraction (LVEF) \u2265 55% measured by echocardiography\r\n             (preferred) or multigated acquisition (MUGA) scan.\r\n\r\n          5. Adequate hematological function.\r\n\r\n          6. Adequate hepatic function.\r\n\r\n          7. Adequate renal function.\r\n\r\n          8. Effective contraception for women of child bearing potential (WOCBP) patients as\r\n             defined by World Health Organization (WHO) guidelines for 1 \"highly effective\" method\r\n             or 2 \"effective\" methods.\r\n\r\n        Inclusion Criteria: Dose Escalation\r\n\r\n          1. Evidence of objective disease, but participation does not require a measurable lesion.\r\n\r\n          2. Locally advanced or metastatic solid tumors, for which no standard therapy exists, or\r\n             standard therapy has failed.\r\n\r\n          3. HER2 expression by immunohistochemistry and/or erbb2 amplification and/or erbb2\r\n             activating mutations must be documented on either archival tissue or fresh tumor\r\n             biopsy.\r\n\r\n        Inclusion Criteria: \"3+3\" Nivolumab Combination Cohort\r\n\r\n          1. Eligible to receive nivolumab per its label for a malignancy of epithelial origin; or\r\n\r\n          2. Have no standard therapy available, or standard therapy has failed, and must not have\r\n             received nivolumab prior to joining the study.\r\n\r\n          3. HER2 expression by immunohistochemistry and/or erbb2 amplification and/or erbb2\r\n             activating mutations must be documented on either archival tissue or fresh tumor\r\n             biopsy.\r\n\r\n        Inclusion Criteria: \"3+3\" Nab paclitaxel Combination Cohort\r\n\r\n          1. Patients must be eligible for treatment with nab-paclitaxel per its label, which\r\n             includes metastatic breast cancer, after failure of combination chemotherapy for\r\n             metastatic disease or relapse within 6 months of adjuvant chemotherapy. In this case,\r\n             additional inclusion criteria include also no exposure to taxanes in the last 6\r\n             months, OR\r\n\r\n          2. Patients whose tumor has no standard therapy or for which standard therapy has failed.\r\n             In this case, patients should also not have been treated with a taxane over the last 6\r\n             months, OR\r\n\r\n          3. First line advanced (unresectable/recurrent/metastatic) TNBC\r\n\r\n          4. HER2 expression by immunohistochemistry and/or erbb2 amplification and/or erbb2\r\n             activating mutations must be documented on either archival tissue or fresh tumor\r\n             biopsy\r\n\r\n        Inclusion Criteria: Safety/PK/PD Expansion Cohorts (Monotherapy and Combination Therapy)\r\n\r\n          1. Fresh tumor biopsy must be obtained during the screening window.\r\n\r\n          2. HER2 expression by immunohistochemistry (IHC).\r\n\r\n          3. Disease must be measurable with at least 1 unidimensional measurable lesion by RECIST\r\n             1.1.\r\n\r\n        Inclusion Criteria: Urothelial Bladder Cancer Expansion Cohort(s)\r\n\r\n          1. Disease must be measurable with at least 1 unidimensional measurable lesion by RECIST\r\n             1.1.\r\n\r\n          2. Histologically or cytologically documented locally advanced or metastatic transitional\r\n             cell carcinoma of the urothelium (including renal pelvis, ureters, urinary urothelial,\r\n             urethra).\r\n\r\n          3. Patients must have radiographic disease progression after their last line of therapy.\r\n\r\n          4. Patients must have received a platinum containing chemotherapy and an anti PD-1 or\r\n             anti PD-L1 for the treatment of urothelial bladder cancer.\r\n\r\n          5. Patients must have experienced radiographic progression of disease during treatment\r\n             with PD-1/PD-L1 containing therapy.\r\n\r\n          6. Patients must have at least 1+ expression of HER2 by IHC.\r\n\r\n          7. For patients that will receive DF1001 in combination with nivolumab: progression while\r\n             under anti PD-(L)1 must have occurred within 6 months of patient inclusion\r\n\r\n          8. A fresh tumor biopsy must be obtained during the screening window.\r\n\r\n        Inclusion Criteria: Breast Cancer (HER2 Low) Expansion Cohort\r\n\r\n          1. Disease must be measurable with at least 1 unidimensional measurable lesion by RECIST\r\n             1.1\r\n\r\n          2. Histologically documented (metastatic or locally advanced) breast cancer.\r\n\r\n          3. Absence of erbb2 amplification by ISH and/or HER2 IHC of 0, 1+, or 2+. If Herceptest\r\n             score is 0, HER2 must be detected by IHC on at least 1+ of the tumor cells.\r\n\r\n          4. Patient must have progressed after one line of systemic chemotherapy. Treatment with a\r\n             trastuzumab-containing ADC will be considered as a line of chemotherapy.\r\n\r\n          5. Patients must have progressed (radiographically) after their last line of systemic\r\n             therapy.\r\n\r\n          6. HR-positive patients must have received hormone therapy and have progressed while\r\n             receiving hormone therapy.\r\n\r\n          7. A fresh tumor biopsy must be obtained during the screening window.\r\n\r\n        Inclusion Criteria: Breast Cancer (HER2 High) Expansion Cohort\r\n\r\n          1. Disease must be measurable with at least 1 unidimensional measurable lesion by RECIST\r\n             1.1\r\n\r\n          2. Histologically documented (metastatic or locally advanced) breast cancer.\r\n\r\n          3. Erbb2 amplification by ISH and/or HER2 IHC of 3+, or 2+. If Herceptest score is 2+,\r\n             ISH results should demonstrate erbb2 amplification.\r\n\r\n          4. Patient must have received trastuzumab, pertuzumab, and a HER2-targeting ADC. Other\r\n             anti HER2 lines of therapy are acceptable.\r\n\r\n          5. Patient must have progressed after one line of systemic chemotherapy.\r\n\r\n          6. HR-positive patients must have received hormone therapy and have progressed while\r\n             receiving hormone therapy.\r\n\r\n          7. A fresh tumor biopsy must be obtained during the screening window.\r\n\r\n        Inclusion Criteria: Basket erbb2 amplified Expansion Cohort\r\n\r\n          1. Disease must be measurable with at least 1 unidimensional measurable lesion by RECIST\r\n             1.1.\r\n\r\n          2. Patients with any solid tumor except breast cancer, gastric cancer, or esophageal\r\n             cancer that have progressed after an HER2 targeting ADC, or patients with carcinoma of\r\n             the salivary glands that have progressed after one line of systemic therapy\r\n\r\n          3. Documented history of erbb2 amplification.\r\n\r\n          4. Patients must have received at least one line of an approved or established therapy.\r\n\r\n          5. A fresh tumor biopsy must be obtained during the screening window.\r\n\r\n        Inclusion Criteria: Gastric Cancer (HER2 High) Expansion Cohort\r\n\r\n          1. Disease must be measurable with at least 1 unidimensional measurable lesion by RECIST\r\n             1.1.\r\n\r\n          2. Advanced (unresectable/recurrent/metastatic) gastric cancer or cancer of the\r\n             gastro-esophageal junction.\r\n\r\n          3. Tumor must have been declared HER2 positive.\r\n\r\n          4. Patients must have received a first line of therapy that included a platinum salt and\r\n             a fluoropyridine in combination with trastuzumab or a biosimilar to trastuzumab.\r\n\r\n          5. Patients must have progressed after the first line therapy.\r\n\r\n          6. Patients must have received only one line of therapy for the treatment of metastatic\r\n             disease.\r\n\r\n          7. A fresh tumor biopsy must be obtained during the screening window.\r\n\r\n        Inclusion Criteria: Gastric Cancer (HER2 Low) Expansion Cohort\r\n\r\n          1. Disease must be measurable with at least 1 unidimensional measurable lesion by RECIST\r\n             1.1.\r\n\r\n          2. Advanced (unresectable/recurrent/metastatic) gastric cancer or cancer of the\r\n             gastro-esophageal junction.\r\n\r\n          3. Tumor must have been declared HER2 low; ISH non-amplified and/or HER2 IHC of 0, 1+ or\r\n             2+. If Herceptest score is 0, HER2 must be detected by IHC on at least 1+ of the tumor\r\n             cells.\r\n\r\n          4. Patients must have received a first line of therapy that included a platinum salt and\r\n             a fluoropyridine in combination with an anti PD-1\r\n\r\n          5. Patients must have progressed after the first line therapy.\r\n\r\n          6. Progression while under anti PD-(L)1 must have occurred within 6 months of patient\r\n             inclusion\r\n\r\n          7. Patients must have received only one line of therapy for the treatment of metastatic\r\n             disease.\r\n\r\n          8. Disease must be measurable with at least 1 unidimensional measurable lesion by RECIST\r\n             1.1.\r\n\r\n          9. A fresh tumor biopsy must be obtained during the screening window.\r\n\r\n        Inclusion Criteria: Esophageal Cancer (HER2 High) Expansion Cohort\r\n\r\n          1. Disease must be measurable with at least 1 unidimensional measurable lesion by RECIST\r\n             1.1.\r\n\r\n          2. Advanced (unresectable/recurrent/metastatic) esophageal cancer.\r\n\r\n          3. Tumor must have been declared HER2 positive.\r\n\r\n          4. Patients must have received a first line of therapy that included a platinum salt and\r\n             a fluoropyridine in combination with trastuzumab or a biosimilar to trastuzumab.\r\n\r\n          5. Patients must have progressed after the first line therapy.\r\n\r\n          6. Patients must have received only one line of therapy for the treatment of metastatic\r\n             disease.\r\n\r\n          7. A fresh tumor biopsy must be obtained during the screening window.\r\n\r\n        Inclusion Criteria: Esophageal Cancer (HER2 Low) Expansion Cohort\r\n\r\n          1. Disease must be measurable with at least 1 unidimensional measurable lesion by RECIST\r\n             1.1.\r\n\r\n          2. Advanced (unresectable/recurrent/metastatic) esophageal cancer.\r\n\r\n          3. Tumor must have been declared HER2 low; ISH non-amplified and/or HER2 IHC of 0, 1+ or\r\n             2+. If Herceptest score is 0, HER2 must be detected by IHC on at least 1+ of the tumor\r\n             cells.\r\n\r\n          4. Patients must have received a first line of therapy that included a platinum salt and\r\n             a fluoropyridine in combination with an anti PD-1\r\n\r\n          5. Patients must have progressed after the first line therapy.\r\n\r\n          6. Progression while under anti PD-(L)1 must have occurred within 6 months of patient\r\n             inclusion\r\n\r\n          7. Patients must have received only one line of therapy for the treatment of metastatic\r\n             disease.\r\n\r\n          8. Disease must be measurable with at least 1 unidimensional measurable lesion by RECIST\r\n             1.1.\r\n\r\n          9. A fresh tumor biopsy must be obtained during the screening window.\r\n\r\n        Inclusion Criteria: Non-small Cell Lung Cancer (HER2 Low) Expansion Cohort\r\n\r\n          1. Disease must be measurable with at least 1 unidimensional measurable lesion by RECIST\r\n             1.1.\r\n\r\n          2. Histologically confirmed NSCLC meeting stage criteria for stage IIIB, stage IV, or\r\n             recurrent disease that has been confirmed to have HER2 expression (at least 1+,\r\n             however, patients must not carry an erbb2 amplification) via archival or fresh biopsy\r\n             tissue prior to study enrollment.\r\n\r\n          3. Patients must have recurrent or progressive disease during or after platinum\r\n             doublet-based chemotherapy OR must have recurrent or progressive disease within 6\r\n             months after completing platinum-based chemotherapy for local disease, including those\r\n             with actionable genetic alterations.\r\n\r\n          4. Patients must have received and progressed on or after anti-PD-(L)1 therapy including\r\n             those with actionable genomic alterations for which an approved treatment exists\r\n\r\n          5. Progression while under anti PD-(L)1 must have occurred within 6 months of patient\r\n             inclusion\r\n\r\n          6. Status for actionable mutations (EGFR, ALK, ROS1, RET, etc.) must be known (when\r\n             testing is available as per country/region standard of care practices); patients with\r\n             actionable mutations must have received and progressed on, have been intolerant to, or\r\n             not be a candidate for standard tyrosine kinase inhibitors (TKIs) (as available per\r\n             country/region standard of care practices).\r\n\r\n          7. A fresh tumor biopsy must be obtained during the screening window.\r\n\r\n        Inclusion Criteria: Non-small Cell Lung Cancer (HER2 High) Expansion Cohort\r\n\r\n          1. Disease must be measurable with at least 1 unidimensional measurable lesion by RECIST\r\n             1.1.\r\n\r\n          2. Histologically confirmed NSCLC meeting stage criteria for stage IIIB, stage IV, or\r\n             recurrent disease that has been confirmed to have amplification of erbb2 via archival\r\n             or fresh biopsy tissue prior to study enrollment.\r\n\r\n          3. Patients must have recurrent or progressive disease during or after platinum\r\n             doublet-based chemotherapy OR must have recurrent or progressive disease within 6\r\n             months after completing platinum-based chemotherapy for local disease, including those\r\n             with actionable genetic alterations.\r\n\r\n          4. Patients must have received and progressed on or after anti-PD-(L)1 therapy including\r\n             those with actionable genomic alterations for which an approved treatment exists\r\n\r\n          5. Status for actionable mutations (EGFR, ALK, ROS1, RET, etc.) must be known (when\r\n             testing is available as per country/region standard of care practices); patients with\r\n             actionable mutations must have received and progressed on, have been intolerant to, or\r\n             not be a candidate for standard tyrosine kinase inhibitors (TKIs) (as available per\r\n             country/region standard of care practices).\r\n\r\n          6. Patients with an erbb2 amplification must provide archival tissue. If archival tissue\r\n             is not available, a fresh biopsy must be obtained during the screening window.\r\n\r\n        Exclusion Criteria:\r\n\r\n        1. Concurrent treatment with a non-permitted drug as in Non-Permitted Medicines and\r\n        Therapies section. Previous treatment with drugs that specifically target the HER2 pathway\r\n        (mAb or tyrosine kinase inhibitor [TKI]) is acceptable providing washout period (4 weeks\r\n        for mAbs or protein therapeutics and 2 weeks for a TKI).\r\n\r\n        2. Concurrent anticancer treatment (eg, cytoreductive therapy, radiotherapy [with the\r\n        exception of palliative bone directed radiotherapy], immune therapy, or cytokine therapy\r\n        except for erythropoietin), major surgery (excluding prior diagnostic biopsy), concurrent\r\n        systemic therapy with steroids or other immunosuppressive agents, or use of any\r\n        investigational drug within 28 days before the start of study treatment. Short-term\r\n        administration of systemic steroids (i.e., for allergic reactions or the management of\r\n        immune-related adverse events [irAEs]) is allowed.\r\n\r\n          1. Note: Patients receiving bisphosphonates are eligible provided treatment was initiated\r\n             at least 14 days before the first dose of DF1001.\r\n\r\n          2. Previous malignant disease other than the target malignancy to be investigated in this\r\n             study within the last 3 years, with the exception of basal or squamous cell carcinoma\r\n             of the skin or cervical carcinoma in situ.\r\n\r\n          3. Rapidly progressive disease.\r\n\r\n          4. Active or history of central nervous system (CNS) metastases.\r\n\r\n          5. Receipt of any organ transplantation including autologous or allogeneic stem-cell\r\n             transplantation.\r\n\r\n          6. Significant acute or chronic infections (including historic positive test for human\r\n             immunodeficiency virus [HIV], or active or latent hepatitis B or active hepatitis C\r\n             tested during the screening window).\r\n\r\n          7. Preexisting autoimmune disease (except for patients with vitiligo) needing treatment\r\n             with systemic immunosuppressive agents for more than 28 days within the last 3 years\r\n             or clinically relevant immunodeficiencies (eg, dys-gammaglobulinemia or congenital\r\n             immunodeficiencies), or fever within 7 days of Day 1.\r\n\r\n          8. Known severe hypersensitivity reactions to mAbs (\u2265 Grade 3 NCI-CTCAE v5.0), any\r\n             history of anaphylaxis, or uncontrolled asthma (ie, 3 or more features of partly\r\n             controlled asthma).\r\n\r\n          9. Persisting toxicity related to prior therapy > Grade 1 NCI-CTCAE v5.0, however\r\n             alopecia and sensory neuropathy \u2264 Grade 2 is acceptable.\r\n\r\n         10. Pregnancy or lactation in females during the study.\r\n\r\n         11. Known alcohol or drug abuse.\r\n\r\n         12. Serious cardiac illness\r\n\r\n         13. NYHA III of IV heart failure or systolic dysfunction (LVEF < 55%)\r\n\r\n         14. High-risk uncontrolled arrhythmias ie, tachycardia with a heart rate > 100/min at rest\r\n\r\n         15. Significant ventricular arrhythmia (ventricular tachycardia) or higher-grade\r\n             Atrioventricular block (AV-block; second-degree AV-block Type 2 [Mobitz 2] or\r\n             third-degree AV-block)\r\n\r\n         16. Angina pectoris requiring anti-anginal medication\r\n\r\n         17. Clinically significant valvular heart disease\r\n\r\n         18. Evidence of transmural infarction on ECG\r\n\r\n         19. Poorly controlled hypertension (defined by: systolic > 180 mm Hg or diastolic > 100 mm\r\n             Hg)\r\n\r\n         20. Clinically relevant uncontrolled cardiac risk factors, clinically relevant pulmonary\r\n             disease or any clinically relevant medical condition in the opinion of the\r\n             Investigator that may limit participation in this study.\r\n\r\n         21. Severe dyspnea at rest due to complications of advanced malignancy or requiring\r\n             supplementary oxygen therapy.\r\n\r\n         22. All other significant diseases (e.g., inflammatory bowel disease), which, in the\r\n             opinion of the Investigator, might impair the patient's ability to participate\r\n\r\n         23. Any psychiatric condition that would prohibit the understanding or rendering of\r\n             informed consent.\r\n\r\n         24. Legal incapacity or limited legal capacity.\r\n\r\n         25. Incapable of giving signed informed consent, which includes compliance with the\r\n             requirements and restrictions listed in the informed consent form (ICF) and in this\r\n             protocol ."
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": null,
        "official_title": "A Phase I/II, First-In-Human, Multi-Part, Open-Label, Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of DF1001 in Patients With Locally Advanced or Metastatic Solid Tumors, and Expansion in Selected Indications",
        "_phase_sort_order": 3,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Through 90 days after completion of the study, an average of 1 year.",
                "name": "Assess Best Overall Response",
                "description": "To assess Best Overall Response (BOR) by IERC (efficacy expansion cohorts).",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Through 90 days after completion of the study, an average of 1 year.",
                "name": "Assess BOR by Investigator Assessment.",
                "description": "To assess confirmed BOR by Investigator Assessment for patients enrolled in the dose escalation phase and in the efficacy expansion phase.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From time of initiation of therapy until the date of first documented tumor progression, assessed up to 24 months",
                "name": "Assess DOR by Investigator Assessment.",
                "description": "To assess DOR for confirmed responses by Investigator Assessment for patients enrolled in the dose escalation phase and in the efficacy expansion phase.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From time of initiation of therapy until the date of first documented tumor progression, assessed up to 24 months",
                "name": "Assess Duration of Response",
                "description": "To assess Duration of Response (DOR) for confirmed responses of DF1001 per an IERC (efficacy expansion cohorts).",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "First 3 weeks of treatment for each subject.",
                "name": "Assessment of number of dose limiting toxicities experienced on study as defined per criteria in the study protocol",
                "description": "To assess the number of adverse events experienced during the study that meet dose limiting toxicity criteria per the study protocol.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Screening visit up to 28 days after last treatment on study.",
                "name": "Assess number of adverse events observed during treatment with DF1001 in combination with Nab paclitaxel",
                "description": "To assess the safety of DF1001 in Combination therapy with Nab paclitaxel by measuring Number of subjects with Treatment-Emergent Adverse Events according to the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) Version 5.0",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Screening visit up to 28 days after last treatment on study.",
                "name": "Assess number of adverse events observed during treatment with DF1001 in combination with Nivolumab",
                "description": "To assess the safety of DF1001 in Combination therapy with nivolumab by measuring Number of subjects with Treatment-Emergent Adverse Events according to the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) Version 5.0",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "From time of initiation of therapy until the date of first documented tumor progression, assessed up to 24 months",
                "name": "Assess ORR by Investigator Assessment.",
                "description": "To assess confirmed ORR by Investigator Assessment for patients enrolled in the dose escalation phase and in the efficacy expansion phase.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Through 90 days after completion of the study, an average of 1 year.",
                "name": "Assess Overall Response Rate",
                "description": "To assess the Overall Response Rate (ORR) per RECIST version 1.1 criteria per an Independent Endpoint Review Committee (IERC)",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Time from enrollment in the study until death, measured up to 2 years after last treatment on study.",
                "name": "Assess Overall Survival (OS) Time.",
                "description": "To assess Overall Survival (OS)",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From time of initiation of therapy until the date of first documented tumor progression, assessed up to 24 months",
                "name": "Assess PFS by Investigator Assessment.",
                "description": "To assess PFS by Investigator Assessment for patients enrolled in the dose escalation phase and in the efficacy expansion phase.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From time of initiation of therapy until the date of first documented tumor progression, assessed up to 24 months",
                "name": "Assess Progression Free Survival (PFS)",
                "description": "To assess Progression Free Survival (PFS) for DF1001 per an IERC (efficacy expansion cohorts).",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Every 3 weeks up to 28 days after last treatment.",
                "name": "Evaluation of DF1001 Immunogenicity",
                "description": "Evaluate the immunogenicity of DF1001 by measuring the number of patients developing anti-DF1001 antibodies",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From start of treatment up through 28 days after last treatment.",
                "name": "Evaluation of DF1001 Pharmacokinetics",
                "description": "Concentration vs time of DF1001 will be measured using blood samples taken a various time points on study",
                "type_code": "SECONDARY"
            }
        ],
        "phase": "I_II",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 17,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT04143711",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Expressed",
                    "Expression Detected"
                ],
                "nci_thesaurus_concept_id": "C177692",
                "name": "Expression Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C35682",
                    "C36292"
                ],
                "parents": [
                    "C35682"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25872",
                "name": "Kinase Family Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C25871",
                    "C21281",
                    "C25870",
                    "C16612"
                ],
                "parents": [
                    "C25871"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25871",
                "name": "Phosphotransferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C25870",
                    "C16612"
                ],
                "parents": [
                    "C25870"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21295",
                "name": "Ligand Binding Protein Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20103",
                "name": "Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612",
                    "C21295"
                ],
                "parents": [
                    "C21295"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Lab Value",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Positive",
                    "positive test result"
                ],
                "nci_thesaurus_concept_id": "C35682",
                "name": "Positive Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C36292"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20719",
                "name": "Receptor Tyrosine Kinase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612",
                    "C20103",
                    "C25872",
                    "C25871",
                    "C25870",
                    "C21295"
                ],
                "parents": [
                    "C20103",
                    "C25872"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2",
                    "Erb-b2 Receptor Tyrosine Kinase 2 Gene",
                    "HER2",
                    "HER2/Neu",
                    "NEU"
                ],
                "nci_thesaurus_concept_id": "C17756",
                "name": "ERBB2 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C20719",
                    "C21295",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C25872",
                    "C25870"
                ],
                "parents": [
                    "C20719"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ERBB2 Positive",
                    "HER-2 Positive",
                    "HER2 Positive"
                ],
                "nci_thesaurus_concept_id": "C68748",
                "name": "HER2/Neu Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C177692",
                    "C21281",
                    "C17756",
                    "C25871",
                    "C25872",
                    "C94299",
                    "C35682",
                    "C36292",
                    "C21295",
                    "C77140",
                    "C16612",
                    "C16152",
                    "C20719",
                    "C3367",
                    "C25870",
                    "C20103"
                ],
                "parents": [
                    "C16152",
                    "C17756",
                    "C177692"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2 Status",
                    "Her2/Neu Value"
                ],
                "nci_thesaurus_concept_id": "C16152",
                "name": "HER2/Neu Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C94299",
                    "C20719",
                    "C21295",
                    "C77140",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C3367",
                    "C25872",
                    "C17756",
                    "C25870",
                    "C36292"
                ],
                "parents": [
                    "C17756",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25870",
                "name": "Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C94299",
                "name": "Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C36292",
                    "C3367"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2019-11-11",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Solid Neoplasm",
                    "Metastatic Malignant Solid Neoplasm",
                    "Metastatic Solid Tumor"
                ],
                "nci_thesaurus_concept_id": "C127155",
                "name": "Metastatic Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Advanced Solid Tumor",
                    "Advanced Solid Neoplasm",
                    "Advanced Non-Hematologic Malignancy",
                    "Advanced Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C129707",
                "name": "Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9270",
                    "C127155"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Locally Advanced Solid Tumor",
                    "Locally Advanced Malignant Solid Neoplasm",
                    "Locally Advanced Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C133093",
                "name": "Locally Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8524",
                    "C127155"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage III Breast Cancer AJCC v8",
                    "Anatomic Stage III Breast Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139541",
                "name": "Stage III Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139533"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage IV Breast Carcinoma AJCC v8",
                    "Anatomic Stage IV Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139545",
                "name": "Stage IV Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139533"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage III Renal Pelvis Cancer AJCC v8",
                    "Stage III Renal Pelvis Urothelial Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140371",
                "name": "Stage III Renal Pelvis Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140356",
                    "C140370"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage III Ureter Cancer AJCC v8",
                    "Stage III Ureter Urothelial Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140372",
                "name": "Stage III Ureter Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140357",
                    "C140370"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Renal Pelvis Cancer AJCC v8",
                    "Stage IV Renal Pelvis Urothelial Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140374",
                "name": "Stage IV Renal Pelvis Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140356",
                    "C140373"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Ureter Cancer AJCC v8",
                    "Stage IV Ureter Urothelial Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140375",
                "name": "Stage IV Ureter Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140373",
                    "C140357"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage III Bladder Carcinoma AJCC v8",
                    "Stage III Bladder Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140421",
                "name": "Stage III Bladder Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140416"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Bladder Carcinoma AJCC v8",
                    "Stage IV Bladder Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140424",
                "name": "Stage IV Bladder Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140416"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage III Urethral Carcinoma AJCC v8",
                    "Stage III Urethral Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140462",
                "name": "Stage III Urethral Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140457"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Urethral Carcinoma AJCC v8",
                    "Stage IV Urethral Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140463",
                "name": "Stage IV Urethral Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140457"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Urethral Urothelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C150512",
                "name": "Metastatic Urethral Urothelial Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27819",
                    "C126109",
                    "C6166"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Bladder Urothelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C150513",
                "name": "Metastatic Bladder Urothelial Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156062",
                    "C39851",
                    "C126109"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Renal Pelvis Urothelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C150514",
                "name": "Metastatic Renal Pelvis Urothelial Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8064",
                    "C163965",
                    "C7355"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Ureter Urothelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C150515",
                "name": "Metastatic Ureter Urothelial Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4830",
                    "C8064",
                    "C27818"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153238",
                "name": "Metastatic Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4872",
                    "C170728",
                    "C3482"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C162616",
                "name": "Locally Advanced Ureter Urothelial Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C150515",
                    "C164159"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C162617",
                "name": "Locally Advanced Renal Pelvis Urothelial Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C150514",
                    "C164159",
                    "C172277"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C162618",
                "name": "Locally Advanced Bladder Urothelial Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C157636",
                    "C150513",
                    "C167071"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C162619",
                "name": "Locally Advanced Urethral Urothelial Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C157636",
                    "C150512"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C162648",
                "name": "Advanced Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C153238",
                    "C153171"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C163954",
                "name": "Advanced Bladder Urothelial Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C167338",
                    "C148493",
                    "C150513"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C163955",
                "name": "Advanced Ureter Urothelial Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C172276",
                    "C150515"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C163963",
                "name": "Advanced Urethral Urothelial Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C150512",
                    "C148493"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C172278",
                "name": "Advanced Renal Pelvis Urothelial Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C163966",
                    "C172276",
                    "C150514"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Tumor, malignant, NOS",
                    "Malignancy",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease",
                    "Malignant Growth",
                    "CA",
                    "Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Solid Neoplasm",
                    "Solid Tumour",
                    "Solid tumor, NOS"
                ],
                "nci_thesaurus_concept_id": "C9292",
                "name": "Solid Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C132146",
                "name": "Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Cancer",
                    "Secondary Malignancy"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36255",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Diseases",
                    "Disease",
                    "Diseases and Disorders",
                    "disease_term",
                    "Diagnosis",
                    "Disease or Disorder, Non-Neoplastic",
                    "disease type",
                    "Disorders",
                    "Disease or Disorder",
                    "Disorder",
                    "condition",
                    "disease_type"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor, metastatic",
                    "Metastatic Tumor",
                    "Neoplasm, metastatic",
                    "Metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Tumor",
                    "Tumor, secondary",
                    "Neoplasm, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Advanced Cancer"
                ],
                "nci_thesaurus_concept_id": "C9270",
                "name": "Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm",
                    "Neoplasms, NOS",
                    "tumor",
                    "Neoplastic Growth",
                    "Tumor, NOS",
                    "Neoplasia",
                    "Neoplasm, NOS",
                    "Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Transitional Cell Neoplasm of the Urinary Tract"
                ],
                "nci_thesaurus_concept_id": "C39852",
                "name": "Urothelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C6783",
                    "C192666"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Urogenital Carcinoma",
                    "Metastatic Genitourinary Cancer",
                    "Metastatic Genitourinary Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C146893",
                "name": "Metastatic Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C164141",
                    "C3482",
                    "C157774"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma of the Breast",
                    "Cancer of Breast",
                    "Carcinoma of Breast",
                    "Breast cancer, NOS",
                    "Mammary Carcinoma",
                    "Breast Carcinoma",
                    "Cancer of the Breast"
                ],
                "nci_thesaurus_concept_id": "C4872",
                "name": "Breast Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9335",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Locally Advanced Cancer",
                    "regional cancer",
                    "Locally advanced",
                    "Locally Metastatic Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8524",
                "name": "Locally Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C139532",
                "name": "Breast Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor of the Urinary System",
                    "Tumor of Urinary System",
                    "Neoplasm of Urinary System",
                    "Neoplasm of the Urinary System",
                    "Urinary System Tumor"
                ],
                "nci_thesaurus_concept_id": "C3431",
                "name": "Urinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3430",
                    "C156482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C164141",
                "name": "Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C156484"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Urothelial Carcinoma of the Urinary Bladder",
                    "Bladder Urothelial Carcinoma",
                    "Urinary Bladder Urothelial Carcinoma",
                    "Transitional Cell Carcinoma of the Urinary Bladder",
                    "Bladder Transitional Cell Carcinoma",
                    "Urinary Bladder Transitional Cell Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C39851",
                "name": "Bladder Urothelial Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4912",
                    "C4030"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Epithelial Neoplasm",
                    "Epithelial tumor, malignant",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Malignant Epithelioma",
                    "Epithelioma Malignant",
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Epithelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9305",
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Transitional Cell Tumor"
                ],
                "nci_thesaurus_concept_id": "C6783",
                "name": "Transitional Cell Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Kidney and Ureter Tumor",
                    "Renal and Ureteral Neoplasm",
                    "Renal and Ureteral Tumor"
                ],
                "nci_thesaurus_concept_id": "C7514",
                "name": "Kidney and Ureter Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3431"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Bladder Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C140416",
                "name": "Bladder Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4912"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Genitourinary System Malignant Neoplasm",
                    "Metastatic Malignant Genitourinary System Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C157774",
                "name": "Metastatic Genitourinary Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Urogenital Disease",
                    "Genitourinary Disorder"
                ],
                "nci_thesaurus_concept_id": "C156660",
                "name": "Genitourinary System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Urethral Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C140457",
                "name": "Urethral Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C9106"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Renal Pelvis and Ureter Urothelial Carcinoma",
                    "Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter",
                    "Metastatic Transitional Cell Carcinoma of Renal Pelvis and Ureter",
                    "Metastatic Upper Urinary Tract Urothelial Carcinoma",
                    "Metastatic Transitional Cell Cancer of Renal Pelvis and Ureter",
                    "Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter"
                ],
                "nci_thesaurus_concept_id": "C8064",
                "name": "Metastatic Urothelial Cancer of the Renal Pelvis and Ureter",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C126109",
                    "C7716"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Cancer of the Urinary Bladder",
                    "Cancer of Bladder",
                    "Carcinoma of Urinary Bladder",
                    "Carcinoma of Bladder",
                    "Carcinoma of the Bladder",
                    "Bladder Carcinoma",
                    "Cancer of the Bladder",
                    "Carcinoma of the Urinary Bladder",
                    "Cancer of Urinary Bladder",
                    "Urinary Bladder Carcinoma",
                    "Urinary Bladder Cancer"
                ],
                "nci_thesaurus_concept_id": "C4912",
                "name": "Bladder Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C192669",
                    "C9334"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disorder of Urinary System",
                    "urinary tract disorder",
                    "Urologic Disorder"
                ],
                "nci_thesaurus_concept_id": "C3430",
                "name": "Urinary System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Neoplasm of the Renal Pelvis",
                    "Malignant Tumor of the Renal Pelvis",
                    "Malignant Neoplasm of Renal Pelvis",
                    "Malignant Tumor of Renal Pelvis",
                    "Malignant Renal Pelvis Tumor"
                ],
                "nci_thesaurus_concept_id": "C7525",
                "name": "Malignant Renal Pelvis Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7548",
                    "C8404"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C192669",
                "name": "Urinary Tract Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C192668",
                    "C181197"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C27806",
                "name": "Metastatic Kidney Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C146893",
                    "C9384"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasms of Ureter",
                    "Neoplasms of the Ureter",
                    "Tumor of the Ureter",
                    "Neoplasm of Ureter",
                    "Ureteral Tumor",
                    "Neoplasm of the Ureter",
                    "Tumor of Ureter",
                    "Ureter Tumor",
                    "Ureteral Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C3427",
                "name": "Ureter Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27148",
                    "C7514",
                    "C192666"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Renal Pelvis Urothelial Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C140356",
                "name": "Renal Pelvis Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140355",
                    "C7355"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Neoplasm of the Ureter",
                    "Malignant Ureteral Tumor",
                    "Malignant Ureter Tumor",
                    "Malignant Ureteral Neoplasm",
                    "Malignant Tumor of Ureter",
                    "Malignant Tumor of the Ureter",
                    "Malignant Neoplasm of Ureter"
                ],
                "nci_thesaurus_concept_id": "C7543",
                "name": "Malignant Ureter Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C192668",
                    "C3427"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153171",
                "name": "Advanced Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9270",
                    "C3482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Kidney Disease",
                    "Renal Disorder",
                    "Renal Disease",
                    "Renal Disorder, NOS"
                ],
                "nci_thesaurus_concept_id": "C3149",
                "name": "Kidney Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3430"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C167338",
                "name": "Advanced Bladder Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C164143",
                    "C156062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C192666",
                "name": "Urinary Tract Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3431"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Ureter Cancer",
                    "Ureteral Carcinoma",
                    "Carcinoma of Ureter",
                    "Carcinoma of the Ureter"
                ],
                "nci_thesaurus_concept_id": "C8993",
                "name": "Ureter Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7543",
                    "C192669"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Carcinoma of the Urethra",
                    "Metastatic Carcinoma of Urethra"
                ],
                "nci_thesaurus_concept_id": "C27819",
                "name": "Metastatic Urethral Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9106",
                    "C146893"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C172276",
                "name": "Advanced Renal Pelvis and Ureter Urothelial Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C148493",
                    "C8064"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C181197",
                "name": "Urinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C164141",
                    "C9297"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Neoplasm of the Bladder",
                    "Malignant Tumor of Bladder",
                    "Malignant Tumor, Urinary Bladder",
                    "Malignant Tumor of the Bladder",
                    "Malignant Neoplasm of Bladder",
                    "Urinary Bladder Malignant Neoplasm",
                    "Malignant Neoplasm of Urinary Bladder",
                    "Malignant Neoplasm, Bladder",
                    "Malignant Urinary Bladder Neoplasm",
                    "Malignant Neoplasm of the Urinary Bladder",
                    "Malignant Neoplasm, Urinary Bladder",
                    "Malignant Urinary Bladder Tumor",
                    "Malignant Tumor of the Urinary Bladder",
                    "Malignant Tumor of Urinary Bladder",
                    "Malignant Bladder Tumor",
                    "Urinary Bladder Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C9334",
                "name": "Malignant Bladder Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C192668",
                    "C2901"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Urinary Tract Tumor"
                ],
                "nci_thesaurus_concept_id": "C192668",
                "name": "Malignant Urinary Tract Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C192666",
                    "C9297"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Renal Pelvis and Ureter Urothelial Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C140355",
                "name": "Renal Pelvis and Ureter Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7716"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Ureteric Disease",
                    "Ureter Disease",
                    "Ureteric Disorder"
                ],
                "nci_thesaurus_concept_id": "C27148",
                "name": "Ureter Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3430"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C163966",
                "name": "Advanced Renal Pelvis Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C163965",
                    "C172617"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Tumor of Kidney",
                    "Malignant Renal Neoplasm",
                    "Malignant Renal Tumor",
                    "Malignant Neoplasm of Kidney",
                    "Malignant Neoplasm of the Kidney",
                    "Malignant Tumor of the Kidney",
                    "Malignant Kidney Tumor"
                ],
                "nci_thesaurus_concept_id": "C7548",
                "name": "Malignant Kidney Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3150",
                    "C9297"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Transitional Cell Carcinoma of Ureter",
                    "Ureteral Urothelial Cell Carcinoma",
                    "Transitional Cell Carcinoma of the Ureter",
                    "Ureter Urothelial Carcinoma",
                    "Ureter Transitional Cell Carcinoma",
                    "Urothelial Cell Carcinoma of Ureter",
                    "Urothelial Cell Carcinoma of the Ureter",
                    "Ureteral Transitional Cell Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C4830",
                "name": "Ureter Urothelial Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7716",
                    "C8993"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C164143",
                "name": "Advanced Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C153171",
                    "C146893",
                    "C176859"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C36310"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C172617",
                "name": "Advanced Kidney Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27806",
                    "C164143"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C164159",
                "name": "Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8064",
                    "C157636"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Bladder Disease",
                    "Urinary Bladder Disorder"
                ],
                "nci_thesaurus_concept_id": "C2900",
                "name": "Bladder Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3430"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Urothelial Carcinoma",
                    "Metastatic Transitional Cell Carcinoma of the Urinary Tract"
                ],
                "nci_thesaurus_concept_id": "C126109",
                "name": "Metastatic Urothelial Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C129828",
                    "C4030",
                    "C146893"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Urothelial Cell Carcinoma of Renal Pelvis",
                    "Transitional Cell Carcinoma of the Renal Pelvis",
                    "Renal Pelvis Transitional Cell Carcinoma",
                    "Urothelial Cell Carcinoma of the Renal Pelvis",
                    "Transitional Cell Carcinoma of Renal Pelvis",
                    "Renal Pelvis Urothelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C7355",
                "name": "Renal Pelvis Urothelial Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7716",
                    "C6142"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C172618",
                "name": "Locally Advanced Kidney Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27806",
                    "C167069"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C148130",
                "name": "Locally Advanced Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8524",
                    "C3482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Bladder Tumors",
                    "Tumor of the Urinary Bladder",
                    "Urinary Bladder Tumors",
                    "Bladder Tumor",
                    "Tumor of Urinary Bladder",
                    "Urinary Bladder Neoplasm",
                    "Urinary Bladder Neoplasms",
                    "Tumor of the Bladder",
                    "Neoplasm of the Urinary Bladder",
                    "Tumor of Bladder",
                    "Neoplasm of the Bladder",
                    "Neoplasm of Urinary Bladder",
                    "Neoplasm of Bladder",
                    "Urinary Bladder Tumor"
                ],
                "nci_thesaurus_concept_id": "C2901",
                "name": "Bladder Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C192666",
                    "C2900"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Kidney Cancer",
                    "Renal Cancer",
                    "Kidney Carcinoma",
                    "Kidney cancer, NOS",
                    "Renal Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C9384",
                "name": "Kidney (including Renal Cell) Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7548",
                    "C181197"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm of Renal Pelvis",
                    "Tumor of the Renal Pelvis",
                    "Tumor of Kidney Pelvis",
                    "Tumor of the Kidney Pelvis",
                    "Neoplasm of the Renal Pelvis",
                    "Renal Pelvis Tumor",
                    "Kidney Pelvis Tumor",
                    "Tumor of Renal Pelvis",
                    "Neoplasm of Kidney Pelvis",
                    "Neoplasm of the Kidney Pelvis",
                    "Kidney Pelvis Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8404",
                "name": "Renal Pelvis Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3150"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C172277",
                "name": "Locally Advanced Renal Pelvis Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C172618",
                    "C163965"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Urethra Tumor",
                    "Neoplasm of the Urethra",
                    "Tumor of Urethra",
                    "Neoplasm of Urethra",
                    "Urethral Neoplasm",
                    "Urethral Tumor",
                    "Tumor of the Urethra"
                ],
                "nci_thesaurus_concept_id": "C3428",
                "name": "Urethra Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C192666",
                    "C26903"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v8 Anatomic Stage"
                ],
                "nci_thesaurus_concept_id": "C139533",
                "name": "Breast Cancer by AJCC v8 Anatomic Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139532"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma of the Kidney Pelvis",
                    "Carcinoma of the Renal Pelvis",
                    "Carcinoma of Renal Pelvis",
                    "Kidney Pelvis Carcinoma",
                    "Carcinoma of Kidney Pelvis",
                    "Renal Pelvis Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C6142",
                "name": "Renal Pelvis Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7525",
                    "C192669",
                    "C9384"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Tumor of Breast",
                    "Malignant Breast Tumor",
                    "Malignant Tumor of the Breast",
                    "Malignant Neoplasm of Breast",
                    "Malignant Neoplasm of the Breast"
                ],
                "nci_thesaurus_concept_id": "C9335",
                "name": "Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C2910"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C167071",
                "name": "Locally Advanced Bladder Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156062",
                    "C167069"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C4968"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Transitional Carcinoma",
                    "CARCINOMA, UROTHELIAL, MALIGNANT"
                ],
                "nci_thesaurus_concept_id": "C2930",
                "name": "Transitional Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C6783"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Infrequent Tumor"
                ],
                "nci_thesaurus_concept_id": "C7201",
                "name": "Infrequent Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C167069",
                "name": "Locally Advanced Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C148130",
                    "C146893"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C172091",
                "name": "Advanced Transitional Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C153171",
                    "C129828"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Urinary System Tumor"
                ],
                "nci_thesaurus_concept_id": "C9297",
                "name": "Malignant Urinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C3431"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Urethral Urothelial Carcinoma",
                    "Transitional Cell Carcinoma of the Urethra",
                    "Urethral Transitional Cell Carcinoma",
                    "Urethra Transitional Cell Carcinoma",
                    "Transitional Cell Carcinoma of Urethra"
                ],
                "nci_thesaurus_concept_id": "C6166",
                "name": "Urethral Urothelial Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9106",
                    "C4030"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156062",
                "name": "Metastatic Bladder Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C146893",
                    "C4912"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Renal Pelvis and Ureter Transitional Cell Carcinoma",
                    "Renal Pelvis and Ureter Transitional Cell Cancer",
                    "Transitional Cell Carcinoma of Renal Pelvis and Ureter",
                    "Transitional Cell Cancer of Renal Pelvis and Ureter",
                    "Renal Pelvis and Ureter TCC",
                    "Urothelial Carcinoma of the Renal Pelvis and Ureter",
                    "Renal Pelvis and Ureter Urothelial Carcinoma",
                    "Upper Urinary Tract Urothelial Carcinoma",
                    "Urothelial Carcinoma of the Upper Urinary Tract",
                    "TCC of the Renal Pelvis and Ureter",
                    "Transitional Cell Cancer of the Renal Pelvis and Ureter",
                    "TCC of Renal Pelvis and Ureter"
                ],
                "nci_thesaurus_concept_id": "C7716",
                "name": "Renal Pelvis and Ureter Urothelial Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7515",
                    "C4030"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage III Renal Pelvis and Ureter Cancer AJCC v8",
                    "Stage III Renal Pelvis and Ureter Urothelial Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140370",
                "name": "Stage III Renal Pelvis and Ureter Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140355"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor of the Breast",
                    "Tumor of Breast",
                    "Breast Tumor",
                    "Neoplasm of the Breast",
                    "Neoplasm of Breast"
                ],
                "nci_thesaurus_concept_id": "C2910",
                "name": "Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26709",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C176859",
                "name": "Advanced Malignant Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9270",
                    "C157774"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Renal Neoplasm",
                    "Kidney Neoplasm",
                    "Neoplasm of the Kidney",
                    "Neoplasm of Kidney",
                    "Tumor of the Kidney",
                    "Renal Tumors",
                    "Renal Tumor",
                    "Tumor of Kidney"
                ],
                "nci_thesaurus_concept_id": "C3150",
                "name": "Kidney Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3149",
                    "C7514"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Disease",
                    "Breast Diseases"
                ],
                "nci_thesaurus_concept_id": "C26709",
                "name": "Breast Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma of the Upper Urinary Tract",
                    "Upper Urinary Tract Carcinoma",
                    "Renal Pelvis and Ureter Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C7515",
                "name": "Renal Pelvis and Ureter Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C192669",
                    "C7514"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Ureter Urothelial Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C140357",
                "name": "Ureter Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140355",
                    "C4830"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Locally Advanced Urothelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C157636",
                "name": "Locally Advanced Urothelial Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C175493",
                    "C167069",
                    "C126109"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Urethra Disease",
                    "Urethral Disorder",
                    "Urethral Disease"
                ],
                "nci_thesaurus_concept_id": "C26903",
                "name": "Urethra Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3430"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Transitional Cell Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C129828",
                "name": "Metastatic Transitional Cell Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C2930"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Urethral Carcinoma",
                    "Carcinoma of the Urethra",
                    "Carcinoma of Urethra",
                    "Urethra Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C9106",
                "name": "Urethral Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7507",
                    "C7201",
                    "C192669"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C170728",
                "name": "Metastatic Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C9335"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Transitional cell car. -uroth.",
                    "Urothelial/bladder cancer, NOS",
                    "Uroepithelial Carcinoma",
                    "Transitional cell carcinoma of the urothelial tract",
                    "Urothelial tract/bladder cancer, NOS",
                    "Urothelial carcinoma, NOS",
                    "Transitional Cell Carcinoma of the Urinary Tract"
                ],
                "nci_thesaurus_concept_id": "C4030",
                "name": "Urothelial Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C39852",
                    "C192669",
                    "C2930"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor_Morphology",
                    "Tumor Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Genitourinary System Cancer",
                    "Genitourinary Cancer",
                    "Malignant Genitourinary Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C156484",
                "name": "Malignant Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C156482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Urethra Neoplasm",
                    "Malignant Neoplasm of Urethra",
                    "Malignant Urethra Tumor",
                    "Malignant Tumor of the Urethra",
                    "Malignant Urethral Tumor",
                    "Malignant Tumor of Urethra",
                    "Malignant Neoplasm of the Urethra"
                ],
                "nci_thesaurus_concept_id": "C7507",
                "name": "Malignant Urethral Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C192668",
                    "C3428"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Carcinoma of Ureter",
                    "Metastatic Carcinoma of the Ureter"
                ],
                "nci_thesaurus_concept_id": "C27818",
                "name": "Metastatic Ureter Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C146893",
                    "C8993"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C175493",
                "name": "Locally Advanced Transitional Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C148130",
                    "C129828"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Advanced Urothelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C148493",
                "name": "Advanced Urothelial Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C172091",
                    "C126109",
                    "C164143"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Renal Pelvis and Ureter Urothelial Carcinoma AJCC v8",
                    "Stage IV Renal Pelvis and Ureter Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140373",
                "name": "Stage IV Renal Pelvis and Ureter Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140355"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156482",
                "name": "Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C163965",
                "name": "Metastatic Renal Pelvis Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C6142",
                    "C27806"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "DF1001-001",
        "active_sites_count": 15,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Opdivo"
                        ],
                        "nci_thesaurus_concept_id": "C68814",
                        "name": "Nivolumab",
                        "description": "A fully human monoclonal antibody directed against  the  negative immunoregulatory human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1/PCD-1) with immunopotentiation activity.  Nivolumab binds to and blocks the activation of PD-1, an Ig superfamily transmembrane protein, by its ligands PD-L1 and PD-L2, resulting in the activation of T-cells and cell-mediated  immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and effector function through the suppression of P13k/Akt pathway activation.  Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C129822",
                            "C128037"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent",
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "PD-1-targeting Agent",
                            "Programmed Cell Death Protein 1 Inhibitor",
                            "Anti-PD-1 Agent",
                            "Protein PD-1 Inhibitor",
                            "PD-1 Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C124946",
                        "name": "PD1 Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C143250"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibody",
                            "Monoclonal Antibodies"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Antibody",
                            "Antineoplastic Ab",
                            "Anticancer Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-PD-1 Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C128037",
                        "name": "Anti-PD1 Monoclonal Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C124946",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologic, Immunochemical",
                            "Immunologics",
                            "Biologicals",
                            "Biologics",
                            "Biopharmaceuticals",
                            "Biological Products"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biotherapeutic",
                            "Anticancer Biological",
                            "Anti-cancer Biological Agent",
                            "Antineoplastic Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C143250",
                        "name": "Immune Checkpoint Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C141144"
                        ]
                    }
                ],
                "name": "Combination Therapy with DF1001 and Nab-paclitaxel",
                "description": "Combination dose escalation of DF1001 in combination with nab-paclitaxel in patients with select solid tumors.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Opdivo"
                        ],
                        "nci_thesaurus_concept_id": "C68814",
                        "name": "Nivolumab",
                        "description": "A fully human monoclonal antibody directed against  the  negative immunoregulatory human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1/PCD-1) with immunopotentiation activity.  Nivolumab binds to and blocks the activation of PD-1, an Ig superfamily transmembrane protein, by its ligands PD-L1 and PD-L2, resulting in the activation of T-cells and cell-mediated  immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and effector function through the suppression of P13k/Akt pathway activation.  Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C129822",
                            "C128037"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent",
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "PD-1-targeting Agent",
                            "Programmed Cell Death Protein 1 Inhibitor",
                            "Anti-PD-1 Agent",
                            "Protein PD-1 Inhibitor",
                            "PD-1 Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C124946",
                        "name": "PD1 Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C143250"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibody",
                            "Monoclonal Antibodies"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Antibody",
                            "Antineoplastic Ab",
                            "Anticancer Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-PD-1 Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C128037",
                        "name": "Anti-PD1 Monoclonal Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C124946",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologic, Immunochemical",
                            "Immunologics",
                            "Biologicals",
                            "Biologics",
                            "Biopharmaceuticals",
                            "Biological Products"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biotherapeutic",
                            "Anticancer Biological",
                            "Anti-cancer Biological Agent",
                            "Antineoplastic Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C143250",
                        "name": "Immune Checkpoint Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C141144"
                        ]
                    }
                ],
                "name": "Combination Therapy with DF1001 and Nab-paclitaxel Safety/PK/P",
                "description": "Expansion cohort of DF1001 in combination with nab-paclitaxel after evaluation for safety in the Combination Therapy with DF1001 and nab-paclitaxel Dose Escalation arm. Additional pharmacokinetic (PK) and pharmacodynamic (PD) samples included in this arm.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Mitosis Inhibitors",
                            "Mitotic Inhibitor Drugs",
                            "Mitotic Inhibitor Agents",
                            "Antimitotics",
                            "Antimitotic Drugs",
                            "Mitosis Inhibitor Agents",
                            "Mitosis Inhibitor Drugs",
                            "Microtubular Function Inhibitors",
                            "Mitotic Inhibitors"
                        ],
                        "nci_thesaurus_concept_id": "C273",
                        "name": "Antimitotic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C186664"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Taxane-Site Binding Agent"
                        ],
                        "nci_thesaurus_concept_id": "C67437",
                        "name": "Taxane-Pocket Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C25974"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Cytotoxic Chemotherapy Agent",
                            "Cytotoxic Antineoplastic Agent",
                            "Antineoplastic Cytotoxic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C186664",
                        "name": "Cytotoxic Chemotherapeutic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Tubulin Binding Agents"
                        ],
                        "nci_thesaurus_concept_id": "C25974",
                        "name": "Tubulin Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C273"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C61078",
                        "name": "Paclitaxel Preparation",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C67437"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Abraxane"
                        ],
                        "nci_thesaurus_concept_id": "C2688",
                        "name": "Nab-paclitaxel",
                        "description": "A Cremophor EL-free, albumin-stabilized nanoparticle formulation of the natural taxane paclitaxel with antineoplastic activity. Paclitaxel binds to and stabilizes microtubules, preventing their depolymerization and so inhibiting cellular motility, mitosis, and replication. This formulation solubilizes paclitaxel without the use of the solvent Cremophor, thereby permitting the administration of larger doses of paclitaxel while avoiding the toxic effects associated with Cremophor. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C61078"
                        ]
                    }
                ],
                "name": "Combination Therapy with DF1001 and Nivolumab",
                "description": "Combination dose escalation of DF1001 in combination with nivolumab in patients with select solid tumors.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Opdivo"
                        ],
                        "nci_thesaurus_concept_id": "C68814",
                        "name": "Nivolumab",
                        "description": "A fully human monoclonal antibody directed against  the  negative immunoregulatory human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1/PCD-1) with immunopotentiation activity.  Nivolumab binds to and blocks the activation of PD-1, an Ig superfamily transmembrane protein, by its ligands PD-L1 and PD-L2, resulting in the activation of T-cells and cell-mediated  immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and effector function through the suppression of P13k/Akt pathway activation.  Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C129822",
                            "C128037"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent",
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "PD-1-targeting Agent",
                            "Programmed Cell Death Protein 1 Inhibitor",
                            "Anti-PD-1 Agent",
                            "Protein PD-1 Inhibitor",
                            "PD-1 Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C124946",
                        "name": "PD1 Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C143250"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibody",
                            "Monoclonal Antibodies"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Antibody",
                            "Antineoplastic Ab",
                            "Anticancer Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-PD-1 Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C128037",
                        "name": "Anti-PD1 Monoclonal Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C124946",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologic, Immunochemical",
                            "Immunologics",
                            "Biologicals",
                            "Biologics",
                            "Biopharmaceuticals",
                            "Biological Products"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biotherapeutic",
                            "Anticancer Biological",
                            "Anti-cancer Biological Agent",
                            "Antineoplastic Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C143250",
                        "name": "Immune Checkpoint Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C141144"
                        ]
                    }
                ],
                "name": "Combination Therapy with DF1001 and Nivolumab Expansion in Eso",
                "description": "Combination therapy with DF1001 and nivolumab expansion cohort enrolling up to 20 patients with esophageal cancer with documented low expression of HER2 using the recommended phase 2 dose (RP2D) identified in the Combination Therapy with DF1001 and nivolumab arm.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Opdivo"
                        ],
                        "nci_thesaurus_concept_id": "C68814",
                        "name": "Nivolumab",
                        "description": "A fully human monoclonal antibody directed against  the  negative immunoregulatory human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1/PCD-1) with immunopotentiation activity.  Nivolumab binds to and blocks the activation of PD-1, an Ig superfamily transmembrane protein, by its ligands PD-L1 and PD-L2, resulting in the activation of T-cells and cell-mediated  immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and effector function through the suppression of P13k/Akt pathway activation.  Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C129822",
                            "C128037"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent",
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "PD-1-targeting Agent",
                            "Programmed Cell Death Protein 1 Inhibitor",
                            "Anti-PD-1 Agent",
                            "Protein PD-1 Inhibitor",
                            "PD-1 Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C124946",
                        "name": "PD1 Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C143250"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibody",
                            "Monoclonal Antibodies"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Antibody",
                            "Antineoplastic Ab",
                            "Anticancer Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-PD-1 Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C128037",
                        "name": "Anti-PD1 Monoclonal Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C124946",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologic, Immunochemical",
                            "Immunologics",
                            "Biologicals",
                            "Biologics",
                            "Biopharmaceuticals",
                            "Biological Products"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biotherapeutic",
                            "Anticancer Biological",
                            "Anti-cancer Biological Agent",
                            "Antineoplastic Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C143250",
                        "name": "Immune Checkpoint Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C141144"
                        ]
                    }
                ],
                "name": "Combination Therapy with DF1001 and Nivolumab Expansion in Gas",
                "description": "Combination therapy with DF1001 and nivolumab expansion cohort enrolling up to 20 patients with gastric cancer with documented low expression of HER2 using the recommended phase 2 dose (RP2D) identified in the Combination Therapy with DF1001 and nivolumab arm.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    }
                ],
                "name": "Combination Therapy with DF1001 and Nivolumab Expansion in NSC",
                "description": "Combination therapy with DF1001 and nivolumab expansion cohort enrolling up to 20 patients with non-small cell lung cancer with documented low expression of HER2 using the recommended phase 2 dose (RP2D) identified in the Combination Therapy with DF1001 and nivolumab arm.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    }
                ],
                "name": "Combination Therapy with DF1001 and Nivolumab Expansion in Uro",
                "description": "Combination therapy with DF1001 and nivolumab expansion cohort enrolling up to 20 patients with urothelial bladder cancer using the recommended phase 2 dose (RP2D) identified in the Combination Therapy with DF1001 and nivolumab arm.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Mitosis Inhibitors",
                            "Mitotic Inhibitor Drugs",
                            "Mitotic Inhibitor Agents",
                            "Antimitotics",
                            "Antimitotic Drugs",
                            "Mitosis Inhibitor Agents",
                            "Mitosis Inhibitor Drugs",
                            "Microtubular Function Inhibitors",
                            "Mitotic Inhibitors"
                        ],
                        "nci_thesaurus_concept_id": "C273",
                        "name": "Antimitotic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C186664"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Taxane-Site Binding Agent"
                        ],
                        "nci_thesaurus_concept_id": "C67437",
                        "name": "Taxane-Pocket Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C25974"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Cytotoxic Chemotherapy Agent",
                            "Cytotoxic Antineoplastic Agent",
                            "Antineoplastic Cytotoxic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C186664",
                        "name": "Cytotoxic Chemotherapeutic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Tubulin Binding Agents"
                        ],
                        "nci_thesaurus_concept_id": "C25974",
                        "name": "Tubulin Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C273"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C61078",
                        "name": "Paclitaxel Preparation",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C67437"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Abraxane"
                        ],
                        "nci_thesaurus_concept_id": "C2688",
                        "name": "Nab-paclitaxel",
                        "description": "A Cremophor EL-free, albumin-stabilized nanoparticle formulation of the natural taxane paclitaxel with antineoplastic activity. Paclitaxel binds to and stabilizes microtubules, preventing their depolymerization and so inhibiting cellular motility, mitosis, and replication. This formulation solubilizes paclitaxel without the use of the solvent Cremophor, thereby permitting the administration of larger doses of paclitaxel while avoiding the toxic effects associated with Cremophor. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C61078"
                        ]
                    }
                ],
                "name": "Combination Therapy with DF1001 and Nivolumab Safety/PK/PD Exp",
                "description": "Expansion cohort of DF1001 in combination with nivolumab after evaluation for safety in the Combination Therapy with DF1001 and nivolumab Dose Escalation arm. Additional pharmacokinetic (PK) and pharmacodynamic (PD) samples included in this arm.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    }
                ],
                "name": "Monotherapy DF1001 Dose Escalation",
                "description": "Dose escalation cohorts of DF1001 in sequential ascending order.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Opdivo"
                        ],
                        "nci_thesaurus_concept_id": "C68814",
                        "name": "Nivolumab",
                        "description": "A fully human monoclonal antibody directed against  the  negative immunoregulatory human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1/PCD-1) with immunopotentiation activity.  Nivolumab binds to and blocks the activation of PD-1, an Ig superfamily transmembrane protein, by its ligands PD-L1 and PD-L2, resulting in the activation of T-cells and cell-mediated  immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and effector function through the suppression of P13k/Akt pathway activation.  Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C129822",
                            "C128037"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent",
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "PD-1-targeting Agent",
                            "Programmed Cell Death Protein 1 Inhibitor",
                            "Anti-PD-1 Agent",
                            "Protein PD-1 Inhibitor",
                            "PD-1 Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C124946",
                        "name": "PD1 Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C143250"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibody",
                            "Monoclonal Antibodies"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Antibody",
                            "Antineoplastic Ab",
                            "Anticancer Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-PD-1 Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C128037",
                        "name": "Anti-PD1 Monoclonal Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C124946",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologic, Immunochemical",
                            "Immunologics",
                            "Biologicals",
                            "Biologics",
                            "Biopharmaceuticals",
                            "Biological Products"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biotherapeutic",
                            "Anticancer Biological",
                            "Anti-cancer Biological Agent",
                            "Antineoplastic Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C143250",
                        "name": "Immune Checkpoint Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C141144"
                        ]
                    }
                ],
                "name": "Monotherapy DF1001 Expansion in Cancers with Erbb2 Amplificati",
                "description": "Monotherapy expansion cohort enrolling up to 40 patients with solid tumors showing documented erbb2 amplification using the recommended phase 2 dose (RP2D) identified in the Monotherapy Dose Escalation arm.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    }
                ],
                "name": "Monotherapy DF1001 Expansion in Esophageal Cancer",
                "description": "Monotherapy expansion cohort enrolling up to 20 patients with esophageal cancer with documented high expression of HER2 using the recommended phase 2 dose (RP2D) identified in the Monotherapy Dose Escalation arm.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    }
                ],
                "name": "Monotherapy DF1001 Expansion in Gastric Cancer",
                "description": "Monotherapy expansion cohort enrolling up to 20 patients with gastric cancer with documented high expression of HER2 using the recommended phase 2 dose (RP2D) identified in the Monotherapy Dose Escalation arm.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    }
                ],
                "name": "Monotherapy DF1001 Expansion in Metastatic Breast Cancer (HER2",
                "description": "Monotherapy expansion cohort enrolling up to 20 patients with metastatic breast cancer with documented low expression of HER2 using the recommended phase 2 dose (RP2D) identified in the Monotherapy Dose Escalation arm.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Monotherapy DF1001 Expansion in Metastatic Breast Cancer (HER2 High)",
                "description": "Monotherapy expansion cohort enrolling up to 20 patients with metastatic breast cancer with documented high expression of HER2 using the recommended phase 2 dose (RP2D) identified in the Monotherapy Dose Escalation arm.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Opdivo"
                        ],
                        "nci_thesaurus_concept_id": "C68814",
                        "name": "Nivolumab",
                        "description": "A fully human monoclonal antibody directed against  the  negative immunoregulatory human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1/PCD-1) with immunopotentiation activity.  Nivolumab binds to and blocks the activation of PD-1, an Ig superfamily transmembrane protein, by its ligands PD-L1 and PD-L2, resulting in the activation of T-cells and cell-mediated  immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and effector function through the suppression of P13k/Akt pathway activation.  Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C129822",
                            "C128037"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent",
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "PD-1-targeting Agent",
                            "Programmed Cell Death Protein 1 Inhibitor",
                            "Anti-PD-1 Agent",
                            "Protein PD-1 Inhibitor",
                            "PD-1 Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C124946",
                        "name": "PD1 Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C143250"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibody",
                            "Monoclonal Antibodies"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Antibody",
                            "Antineoplastic Ab",
                            "Anticancer Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-PD-1 Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C128037",
                        "name": "Anti-PD1 Monoclonal Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C124946",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologic, Immunochemical",
                            "Immunologics",
                            "Biologicals",
                            "Biologics",
                            "Biopharmaceuticals",
                            "Biological Products"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biotherapeutic",
                            "Anticancer Biological",
                            "Anti-cancer Biological Agent",
                            "Antineoplastic Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C143250",
                        "name": "Immune Checkpoint Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C141144"
                        ]
                    }
                ],
                "name": "Monotherapy DF1001 Expansion in NSCLC",
                "description": "Monotherapy expansion cohort enrolling up to 20 patients with non-small cell lung cancer with documented erbb2 amplification using the recommended phase 2 dose (RP2D) identified in the Monotherapy Dose Escalation arm.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    }
                ],
                "name": "Monotherapy DF1001 Expansion in Urothelial Bladder Cancer",
                "description": "Monotherapy expansion cohort enrolling up to 20 patients with urothelial bladder cancer using the recommended phase 2 dose (RP2D) identified in the Monotherapy Dose Escalation arm.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C172279",
                        "name": "HER2 Tri-specific Natural Killer Cell Engager DF1001",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    }
                ],
                "name": "Monotherapy DF1001 Safety/PK/PD Expansion",
                "description": "Expansion cohorts of monotherapy DF1001 in multiple dose levels after evaluation for safety in Monotherapy Dose Escalation arm. Additional pharmacokinetic (PK) and pharmacodynamic (PD) samples included in this arm.",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2020-03830",
        "why_study_stopped": null,
        "brief_summary": "DF1001-001 is a study of a new molecule that targets natural killer (NK) cells and T-cell\r\n      activation signals to specific receptors on cancer cells. The study will occur in two phases.\r\n      The first phase will be a dose escalation phase, enrolling patients with various types of\r\n      solid tumors that express human epidermal growth factor receptor 2 (HER2). Two combination\r\n      therapy cohorts will be opened for enrollment, DF1001 + nivolumab and DF1001 + Nab\r\n      paclitaxel. The second phase will include a dose expansion using the best dose selected from\r\n      the first phase of the study. Multiple cohorts will be opened with eligible patients having\r\n      either selected solid tumors, or solid tumors expressing high levels of HER2.",
        "brief_title": "Study of DF1001 in Patients With Advanced Solid Tumors",
        "status_history": [
            {
                "status_date": "2019-11-11T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 490,
        "prior_therapy": [],
        "_current_trial_status_sort_order": 0,
        "start_date": "2019-11-11",
        "record_verification_date": "2022-12-01",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Non-Randomized Trial"
        },
        "acronym": null,
        "nci_programs": [],
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Multiple"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2025-12-01",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]